Drug LitigationProzac and Its Potential Pregnancy Risks

September 18, 2012

For years, the Food and Drug Administration (FDA) has cautioned the public about a possible link between Prozac (fluoxetine) and serious infant birth defects, most notably persistent pulmonary hypertension (PPHN). Medical findings conflict about the extent to which pregnant Prozac patients may inadvertently expose their newborns to side effects, but many patients are understandably concerned.

 

Sadly, for many families concern has long since turned into frustration and heartbreak as they have adjusted to the emotional, financial, and physical costs associated with a PPHN birth. Does this sound tragically familiar? If so, it might be time to give us a call.

 

The attorneys at the Dallas law firm believe that families deserve a fair fight, even against massive pharmaceudical companies. It’s why we’ve represented victims like you for years – and it’s why we’re prepared to vigorously defend your legal interests. You can trust your case to our experienced, dedicated, and passionate attorneys. To find out how we may be able to help you and to receive your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to help you.

https://ntrial.com/ntrial/wp-content/uploads/Nachawati-Law-logo-White-2-160x25.png

Our Firm

Press Room

Free Consultation

©2025 Nachawati Law Group           Terms and Conditions | Privacy Policy

https://ntrial.com/ntrial/wp-content/uploads/Nachawati-Law-logo-White-2-160x25.png

Our Firm

Press Room

Free Consultation

©2025 Nachawati Law Group

Terms and Conditions | Privacy Policy